首页> 外文期刊>European journal of human genetics: EJHG >A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/LEOPARD syndrome and Noonan-like/multiple giant cell lesion syndrome.
【24h】

A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/LEOPARD syndrome and Noonan-like/multiple giant cell lesion syndrome.

机译:一种新型的PTPN11基因突变桥接了Noonan综合征,多发性扁桃体/ LEOPARD综合征和Noonan样/多个巨细胞病变综合征。

获取原文
获取原文并翻译 | 示例
           

摘要

Noonan (NS) and multiple lentigines/LEOPARD syndromes (LS) have proved to be associated with distinct PTPN11 mutations. Noonan-like/multiple giant cell lesion syndrome (NLS) is a rare disease, characterised by short stature, facial dysmorphisms, congenital heart defect (CHD) and central giant cell lesions. PTPN11 gene mutations have been reported in a single NLS family and two sporadic patients. Here we report a patient with a complex phenotype progressing throughout the years from NS at birth towards LS and NLS. PTPN11 gene analysis disclosed a novel missense mutation (Ala461Thr) in exon 12, affecting the consensus sequence of the SHP2-active site. This observation joins together NS and LS to NLS into a unique genetic defect, broadening the clinical and molecular spectrum of PTPN11-related disorders.
机译:已证实Noonan(NS)和多种lentigines / LEOPARD综合征(LS)与不同的PTPN11突变有关。 Noonan样/多发性巨细胞病变综合征(NLS)是一种罕见的疾病,其特征是身材矮小,面部畸形,先天性心脏缺陷(CHD)和中央巨细胞病变。在一个NLS家族和两名散发患者中已经报道了PTPN11基因突变。在这里,我们报道了一名患者,从出生时的NS到LS和NLS,这些年来出现了复杂的表型。 PTPN11基因分析揭示了外显子12中有一个新的错义突变(Ala461Thr),影响SHP2活性位点的共有序列。该观察结果将NS和LS结合到NLS上,形成了独特的遗传缺陷,拓宽了PTPN11相关疾病的临床和分子谱。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号